595 Armed myxoma virus demonstrates efficacy in syngeneic tumor models alone and in combination with immune checkpoint inhibitors

• Grant McFadden,
• Lina Franco,
• Lino Torres-Dominguez,
• Joseph Mamola,
• Ana de Matos,
• Mario Abrantes,
• Benjamin Walker,
• Zachary Tacner,
• Cassandra Kien,
• Natalie Elliott,
• Leslie Sharp

Affiliations

Grant McFadden

OncMyx Therapeutics, Phoenix, AZ, USA

Lina Franco

OncMyx Therapeutics, Phoenix, AZ, USA

Lino Torres-Dominguez

OncMyx Therapeutics, Phoenix, AZ, USA

Joseph Mamola

OncMyx Therapeutics, Phoenix, AZ, USA

Ana de Matos

OncMyx Therapeutics, Phoenix, AZ, USA

Mario Abrantes

OncMyx Therapeutics, Phoenix, AZ, USA

Benjamin Walker

OncMyx Therapeutics, Phoenix, AZ, USA

Zachary Tacner

OncMyx Therapeutics, Phoenix, AZ, USA

Cassandra Kien

OncMyx Therapeutics, Phoenix, AZ, USA

Natalie Elliott

OncMyx Therapeutics, Phoenix, AZ, USA

Leslie Sharp

OncMyx Therapeutics, Phoenix, AZ, USA